Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone

Neurocrit Care. 2020 Feb;32(1):348-352. doi: 10.1007/s12028-019-00850-0.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiography, Digital Subtraction
  • Aphasia, Broca / physiopathology
  • Brain Edema / diagnostic imaging
  • Brain Edema / etiology
  • Brain Edema / physiopathology
  • Brain Edema / surgery
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / diagnostic imaging*
  • Cerebral Hemorrhage / physiopathology
  • Computed Tomography Angiography
  • Decompressive Craniectomy
  • Disease Progression
  • Drainage
  • Female
  • Humans
  • Hydrocephalus / etiology
  • Hydrocephalus / physiopathology
  • Hydrocephalus / surgery
  • Hyperemia / diagnostic imaging
  • Middle Cerebral Artery / diagnostic imaging*
  • Middle Cerebral Artery / physiopathology
  • Milrinone / therapeutic use*
  • Nimodipine / therapeutic use
  • Paresis / physiopathology
  • Puerperal Disorders / diagnostic imaging
  • Puerperal Disorders / drug therapy*
  • Puerperal Disorders / physiopathology
  • Severity of Illness Index
  • Treatment Outcome
  • Ultrasonography, Doppler, Transcranial
  • Vasodilator Agents / therapeutic use*
  • Vasospasm, Intracranial / complications
  • Vasospasm, Intracranial / diagnostic imaging
  • Vasospasm, Intracranial / drug therapy*
  • Vasospasm, Intracranial / physiopathology
  • Ventriculostomy

Substances

  • Vasodilator Agents
  • Nimodipine
  • Milrinone